首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   586篇
  免费   31篇
耳鼻咽喉   10篇
儿科学   30篇
妇产科学   10篇
基础医学   68篇
口腔科学   12篇
临床医学   44篇
内科学   118篇
皮肤病学   53篇
神经病学   41篇
特种医学   23篇
外国民族医学   1篇
外科学   76篇
综合类   4篇
预防医学   37篇
眼科学   8篇
药学   30篇
中国医学   1篇
肿瘤学   51篇
  2024年   1篇
  2023年   5篇
  2022年   31篇
  2021年   36篇
  2020年   14篇
  2019年   23篇
  2018年   14篇
  2017年   13篇
  2016年   19篇
  2015年   22篇
  2014年   20篇
  2013年   35篇
  2012年   57篇
  2011年   80篇
  2010年   27篇
  2009年   29篇
  2008年   36篇
  2007年   20篇
  2006年   27篇
  2005年   19篇
  2004年   17篇
  2003年   10篇
  2002年   14篇
  2001年   10篇
  2000年   6篇
  1999年   8篇
  1997年   1篇
  1994年   1篇
  1993年   2篇
  1992年   4篇
  1991年   2篇
  1990年   1篇
  1988年   3篇
  1987年   2篇
  1986年   2篇
  1985年   1篇
  1981年   1篇
  1978年   2篇
  1977年   2篇
排序方式: 共有617条查询结果,搜索用时 0 毫秒
51.
52.
53.
54.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
55.
56.
Sleep disorders are prevalent in young children, the most frequent being disturbances in initiating and maintaining sleep. Behavioral and cognitive approaches are interesting techniques for their management. They can be used either for solving sleep problems at home, or in severe forms as part of a 'deconditioning' during a short hospitalization.  相似文献   
57.
The purpose of this retrospective clinical study is to look into the etiological role of alshammah and alqat consumption in the causation of squamous cell carcinoma of the head and neck (SCHN) in Arabia. Alshammah and alqat are traditional forms of chewable tobacco very commonly used in southern Saudi Arabia and Yemem. In a 2 year period 64 patients with histologically proven SCHN were found. Most of them were originally from southern Saudi Arabia and Yemen. Of these 64 patients 52 (81%) admitted alshammah consumption. Of these 52 patients 22 admitted alqat consumption in addition. Thirty-eight (59%) had oral cancer, while the rest had pharyngeal and laryngeal cancer. All the 38 patients with oral cancer either used alshammah alone (16 patients) or used both alshammah and alqat (22 patients). The median duration of alshammah consumption was 15 years and that of alqat was 12 years. Alcohol was not consumed among the group and only few were cigarette smokers. Most patients presented in the late stage of the disease. The evidence implicating alshammah and alqat in the causation of SCHN is only clinically based. Further controlled prospective clinical and experimental studies are needed to confirm the theory.  相似文献   
58.
The present work has a twofold purpose, the first is to valorize an endemic species of Morocco, which is widely used in traditional medicine and the second to suggest an alternative to synthetic anti-candida products, especially against Candida albicans. It’s about the blue wormwood (Artemisia mesatlantica M.) which is rarely discussed in the literature.In order to do this, the essential oil from a recent technical by microwave (MO) and another traditional by steam distillation (EVE), were analyzed by gas chromatography coupled with mass spectrometry. The anti-candida tests of three essential oils extracted by microwave (MO), hydrodistillation (H) and stream distillation (E.V.E), were performed on five reference strains. Five-fold dilutions were prepared ranging from 50% (v/v) to 3.12% (v/v). The minimum inhibitory concentrations were determined by microdilution.The chemical composition of oils shows that the main components are: β-thujone for both techniques EVE (62,05%) and MO (51,81%), followed by camphor (14.39%) for MO and α- thujone (4.68%) for EVE. The best potential is obtained in the case of the essential oil extracted by microwave. Reference synthetic products were also tested with approved doses and are generally ineffective  相似文献   
59.
60.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号